NOW APPROVED in pediatric patients with moderately to severely active ulcerative colitis who weigh at least 15 kg

FOR HEALTHCARE PROVIDERS

SIMPONI®: An Injection Experience to Consider for Your Patients

Select an indication below for more information:

RA

Adults With Moderate to Severe Rheumatoid Arthritis*

PsA

Adults With Active
Psoriatic Arthritis†

AS

Adults With Active
Ankylosing Spondylitis

visit rheumatoid-arthritis

UC

Adults With
Moderately to Severely Active
Ulcerative Colitis

visit ulcerative-colitis

pUC

Pediatric Patients Weighing at Least 15 kg  
With Moderately to Severely Active
Pediatric Ulcerative Colitis

visit pediatric-ulcerative-colitis
*In combination with methotrexate.
†Alone or in combination with methotrexate.